Annual EBITDA
-$77.06 M
-$25.61 M-49.79%
31 December 2022
Summary:
Rain Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$77.06 million, with the most recent change of -$25.61 million (-49.79%) on 31 December 2022. During the last 3 years, it has fallen by -$56.16 million (-268.76%).RAIN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$7.92 M
+$12.45 M+61.11%
30 September 2023
Summary:
Rain Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$7.92 million, with the most recent change of +$12.45 million (+61.11%) on 30 September 2023.RAIN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$73.56 M
+$10.47 M+12.46%
30 September 2023
Summary:
Rain Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$73.56 million, with the most recent change of +$10.47 million (+12.46%) on 30 September 2023.RAIN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAIN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -268.8% | +57.0% | -89.5% |
| 5 y5 years | - | - | - |
RAIN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +610.7% | +214.1% | +2815.8% |
Rain Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$7.92 M(-61.1%) | -$73.56 M(-12.5%) |
| June 2023 | - | -$20.38 M(-6.2%) | -$84.03 M(+3.3%) |
| Mar 2023 | - | -$21.73 M(-7.7%) | -$81.35 M(+5.6%) |
| Dec 2022 | -$77.06 M(+49.8%) | -$23.54 M(+28.0%) | -$77.06 M(+7.7%) |
| Sept 2022 | - | -$18.39 M(+3.9%) | -$71.57 M(-0.0%) |
| June 2022 | - | -$17.70 M(+1.5%) | -$71.60 M(+15.3%) |
| Mar 2022 | - | -$17.43 M(-3.5%) | -$62.08 M(+20.7%) |
| Dec 2021 | -$51.44 M | -$18.06 M(-2.0%) | -$51.44 M(+32.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$18.42 M(+125.3%) | -$38.82 M(+26.2%) |
| June 2021 | - | -$8.18 M(+20.3%) | -$30.76 M(+22.2%) |
| Mar 2021 | - | -$6.79 M(+25.1%) | -$25.16 M(+20.4%) |
| Dec 2020 | -$20.90 M(+92.7%) | -$5.43 M(-47.6%) | -$20.89 M(+35.1%) |
| Sept 2020 | - | -$10.36 M(+301.8%) | -$15.46 M(+203.1%) |
| June 2020 | - | -$2.58 M(+2.2%) | -$5.10 M(+102.2%) |
| Mar 2020 | - | -$2.52 M | -$2.52 M |
| Dec 2019 | -$10.84 M | - | - |
FAQ
- What is Rain Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Rain Therapeutics?
- What is Rain Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Rain Therapeutics?
- What is Rain Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Rain Therapeutics?
What is Rain Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of RAIN is -$77.06 M
What is the all time high annual EBITDA for Rain Therapeutics?
Rain Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.84 M
What is Rain Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of RAIN is -$7.92 M
What is the all time high quarterly EBITDA for Rain Therapeutics?
Rain Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$2.52 M
What is Rain Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of RAIN is -$73.56 M
What is the all time high TTM EBITDA for Rain Therapeutics?
Rain Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.52 M